Melinta Therapeutics Inc (NASDAQ: MLNT) was one of the biggest losers in yesterday’s trading session. This came after the company announced that, it had filed for chapter 11 bankruptcy protection. It announced that under its senior credit facility, named the Deerfield Private Design